Atezolizumab in patients (pts) with locally-advanced or metastatic urothelial carcinoma (mUC): Results from a pivotal multicenter phase II study (IMvigor 210)
Authors
Rosenberg, J; Petrylak, D; Abidoye, O; Van der Heijden, MS; Hofman-Censits, J; Necchi, A; O'Donnell, PH; Balmanoukian, A; Loriot, Y; Retz, M; Perez-Gracia, JL; Dawson, NA; Balar, A; Galsky, MD; Fleming, MT; Powles, T; Cui, N; Mariathasan, S; Fine, GD; Dreicer, RCollections
Licence information
